Browsing items tagged “Pricentric ONE | EVERSANA”

President Trump Unveils Rules to Lower U.S. Prescription Drug Prices

Country: UNITED STATES | Region: NORTH AMERICA | Type: Policy | Keywords: #discounts #generics #medicare #mostfavorednations #pbms #pharmacybenefitmanagers #prescriptiondrugs #referencepricing(irp) #regulation #unapproveddrugsinitiative PRICENTRIC BRIEF: On Friday afternoon, U.S. President Donald Trump unveiled two rules set to take effect in January that would link U.S. prescription drug prices to those found abroad in economically similar countries and end rebates for pharmacy benefit managers (PBMs), saving American patients, particularly Medicare beneficiaries, “many, […]

BPI Backs Installment Payments, Returning Funds to Health Insurers’ Morbi-RSA Funding Pool

Country: GERMANY | Region: EUROPE | Type: Pricing & Reimbursement | Keywords: #atmp #bpi #cellandgenetherapy #morbirsa #payforperformance #refunds #riskpool #risksharing #statutoryhealthinsurers PRICENTRIC BRIEF: For the Federal Association of the Pharmaceutical Industry (BPI), pay-for-performance (P4P) models are the best way forward for the morbidity-oriented risk-sharing compensation (Morbi-RSA) fund among health insurers The Law for Fair Cash Competition in Statutory Health Insurance (Fairer-Kassenwettbewerb) was passed earlier this year, aiming to level […]

Netherlands Kicks Off Zolgensma Review for BeNeLuxA

Country: AUSTRIA, BELGIUM, IRELAND, LUXEMBOURG, NETHERLANDS | Region: EUROPE | Type: HTA | Keywords: #avexis  #beneluxa #biogen #novartis #spinraza #zorginstituut PRICENTRIC BRIEF: The Netherlands’ Zorginstituut (ZIN) has started its assessment of AveXis/Novartis’ gene therapy Zolgensma (onasemnogene abeparvovec) for the treatment of spinal muscular atrophy (SMA) Following conditional approval for Zolgensma in Europe in May, BeNeLuxA announced Belgium, Ireland, and the Netherlands would undertake […]

Switzerland’s FOPH Lowers Prices of 300 Meds, Set to Save 60M Francs

Country: SWITZERLAND | Region: EUROPE | Type: Pricing & Reimbursement | Keywords: #bag #foph #funding #saving #switzerland PRICENTRIC BRIEF: Switzerland’s Federal Office of Public Health (FOPH) has announced that it has successfully reduced the prices of more than 300 pharmaceuticals by an average of 11% in 2020, as part of the triennial review Because of these price cuts, the group now expects savings of at least 60 million […]

French MPs Vote for PLFSS Amendments Regarding ATU, RTU Schemes

Country: FRANCE | Region: EUROPE | Type: Policy | Keywords: #access #atu #budget #compassionate #drug #early #france #plfss #policy #spending PRICENTRIC BRIEF: French MPs have voted in favor of amendments to the Social Security Finance Bill 2021 (PLFSS 2021), regarding early access (RTU) and managed off-label use (ATU) scheme In accordance with the voting, the new “Early Stage” and “Compassionate Use” schemes will be implemented in order to ensure patients have early, temporary and exceptional […]

Canada Publishes Finalized PMPRB Guidelines Ahead of January 1, 2021 Implementation

Country: UNITED STATES | Region: NORTH AMERICA | Type: Policy | Keywords: : #clinicaltrials #druglaunch #excessivepricing #innovation #marketshare #patientaccess #pmprb #priceceilings #referencepricing(irp) #treatmentcosts PRICENTRIC BRIEF: The Patented Medicine Prices Review Board (PMPRB) has released the final version of the PMPRB guidelines, which are due to take effect on January 1, 2021 As noted by PMPRB, […]

Pricentric Insights: What a Biden Presidency Could Mean for Drug Pricing in the U.S.

Country: UNITED STATES | Region: NORTH AMERICA | Type: Policy | Keywords: #biden #debate #donald #drug #harris #joe #kamala #policy #presidency #pricing #states #trump #united PRICENTRIC BRIEF: With the final presidential debate looming tonight, October 22, and Election Day two weeks away, Democratic presidential nominee Joe Biden’s drug pricing proposals hang primarily on one overarching […]

UK’s MHRA Joins ACSS-Consortium, FDA’s Project Orbis

Country: AUSTRALIA, CANADA-ONTARIO, SINGAPORE, SWITZERLAND, UNITED KINGDOM, UNITED STATES | Region: ASIA & SOUTH PACIFIC, EUROPE, NORTH AMERICA, SOUTH AMERICA | Type: Regulation | Keywords: #acssconsortium #anvisa #concurrentsubmission #fda #healthcanada #hsa #hta #mhra #projectorbis #swissmedic #tga PRICENTRIC BRIEF: The UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) is officially joining the Australia-Canada-Singapore-Switzerland (ACSS) Consortium on January 1, 2021, after first shadowing the Consortium As noted by MHRA, “The addition of the UK brings the combined population of countries participating in the […]

Japan’s Ministry of Health Proposes Finalized Off-Year Re-pricing for All Medicines

Country: JAPAN | Region: ASIA & SOUTH PACIFIC | Type: Pricing & Reimbursement | Keywords: #cost #generics #japan #medicines #mof #moh #nhi #off #patented #pricing #revision #sakigake PRICENTRIC BRIEF: Japan’s Ministry of Finance (MOF) has presented its proposal on the country’s planned off-year drug re-pricing, and called for a total revision of all products including patent-protected medicines, in order to reduce the financial […]

EMA Commences Rolling Review of Second COVID-19 Vaccine

 Country: NETHERLANDS | Region: EU28, EUROPE | Type: Regulation | Keywords: #biontech #chmp #covid19 #ema #pfizer #rollingreview #vaccine PRICENTRIC BRIEF: The European Medicines Agency’s (EMA) human medicines committee (CHMP) has commenced a rolling review of data for Pfizer and BioNTech’s potential COVID-19 vaccine candidate, BNT162b2 CHMP’s decision to start the rolling review of BNT162b2 is based on promising preliminary results from non-clinical trials and early clinical studies, in which it has […]